Luoxin Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 5.65 million yuan, turning a profit compared to a loss in the same period last year
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Luoxin Pharmaceutical disclosed its first-quarter report for 2025, showing that the company achieved revenue of 483 million yuan during the reporting period, a year-on-year decrease of 29.91%; the net profit attributable to the parent company was 5.65 million yuan, turning from a loss to a profit year-on-year; the net profit excluding non-recurring gains and losses was 670,000 yuan, also turning from a loss to a profit year-on-year. The basic earnings per share were 0.01 yuan
According to the Zhitong Finance APP, Luoxin Pharmaceutical (002793.SZ) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 483 million yuan, a year-on-year decrease of 29.91%; the net profit attributable to the parent company was 5.65 million yuan, turning from a loss to a profit year-on-year; the net profit excluding non-recurring gains and losses was 670,000 yuan, also turning from a loss to a profit year-on-year. The basic earnings per share were 0.01 yuan